Why BCBS reversed course on weight loss drug coverage Insurance companies do not make decisions this large without significant financial pressure
M.et al (2020)
Hamasaki, H
People investigating the relationship between GLP-1 and endometriosis should note that endometriosis patients are approximately 80% more likely to develop IBD, making this concern especially pertinent
Moving forward, the results of the phase 3 SURPASS clinical trial program demonstrated that tirzepatide was as effective and safe as other anti-diabetic agents, such as semaglutide and dulaglutide (SURPASS-2) (SURPASS J-mono), long-acting insulin analogs (degludec and glargine) (SURPASS-3,4), and placebo (SURPASS-1) (SURPASS-5), in managing T2DM diabetes [65,66,67,68,69]
The telehealth company Hims, which has sold branded and compounded GLP-1s, recently announced plans to offer a cheaper pill form of the GLP-1